155 related articles for article (PubMed ID: 15291249)
1. [Collagen diseases with pulmonary hypertension].
Endo H; Tanaka S; Sakai M
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Jun; 27(3):127-36. PubMed ID: 15291249
[No Abstract] [Full Text] [Related]
2. [Pulmonary arterial hypertension in connective tissue diseases].
Degano B
Rev Mal Respir; 2006 Dec; 23(6):746-8. PubMed ID: 17886350
[No Abstract] [Full Text] [Related]
3. Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin).
Humbert M; Sanchez O; Fartoukh M; Jagot JL; Sitbon O; Simonneau G
Chest; 1998 Jul; 114(1 Suppl):80S-82S. PubMed ID: 9676646
[No Abstract] [Full Text] [Related]
4. Treatment of pulmonary arterial hypertension.
Humbert M; Sitbon O; Simonneau G
N Engl J Med; 2004 Sep; 351(14):1425-36. PubMed ID: 15459304
[No Abstract] [Full Text] [Related]
5. The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol.
Ramsay MA; Spikes C; East CA; Lynch K; Hein HA; Ramsay KJ; Klintmalm GB
Anesthesiology; 1999 Jan; 90(1):299-301. PubMed ID: 9915339
[No Abstract] [Full Text] [Related]
6. [Pulmonary hypertension].
Olschewski H; Ghofrani A; Wiedemann R; Rose F; Enke B; Gessler T; Voswinckel R; Kohstall M; Grimminger F; Seeger W
Internist (Berl); 2002 Dec; 43(12):1498, 1501-9. PubMed ID: 12607389
[No Abstract] [Full Text] [Related]
7. [Therapeutic management of primary pulmonary hypertension].
Chaouat A; Weitzenblum E
Presse Med; 2002 Feb; 31(7):320-8. PubMed ID: 11899690
[TBL] [Abstract][Full Text] [Related]
8. Medical & surgical approaches to pulmonary hypertension.
McLaughlin VV; Rich S
Compr Ther; 1997 Sep; 23(9):612-6. PubMed ID: 9285162
[TBL] [Abstract][Full Text] [Related]
9. Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study.
Humbert M; Sanchez O; Fartoukh M; Jagot JL; Le Gall C; Sitbon O; Parent F; Simonneau G
Eur Respir J; 1999 Jun; 13(6):1351-6. PubMed ID: 10445611
[TBL] [Abstract][Full Text] [Related]
10. Scheduled perioperative switch from oral sildenafil to intravenous epoprostenol in a patient with Eisenmenger syndrome undergoing a sigmoidectomy.
Moriyama K; Uzawa K; Iijima T; Kotani M; Moriyama K; Ohashi Y; Satoh T; Yorozu T
J Clin Anesth; 2012 Sep; 24(6):487-9. PubMed ID: 22762976
[TBL] [Abstract][Full Text] [Related]
11. The value of approved therapies for pulmonary arterial hypertension.
Rich S
Am Heart J; 2007 Jun; 153(6):889-90. PubMed ID: 17540187
[No Abstract] [Full Text] [Related]
12. Intravenous epoprostenol: a new therapy for primary pulmonary hypertension.
Sabo JA; Nord CP
Crit Care Nurse; 2000 Dec; 20(6):31-40. PubMed ID: 11878257
[No Abstract] [Full Text] [Related]
13. Progress in, and future prospects for, the treatment of primary pulmonary hypertension.
Wilkins MR; Wharton J
Heart; 2001 Dec; 86(6):603-4. PubMed ID: 11711446
[No Abstract] [Full Text] [Related]
14. Pulmonary arterial hypertension--the primary pulmonary hypertension syndromes.
Hey JC; Scharf SM
Isr Med Assoc J; 2003 Apr; 5(4):298-303. PubMed ID: 14509142
[No Abstract] [Full Text] [Related]
15. Moderate-term effect of epoprostenol on severe portopulmonary hypertension.
Kato H; Katori T; Nakamura Y; Kawarasaki H
Pediatr Cardiol; 2003; 24(1):50-3. PubMed ID: 12574979
[TBL] [Abstract][Full Text] [Related]
16. Vasodilators in the treatment of primary pulmonary hypertension.
Weir EK; Schremmer B
Eur Respir J; 1998 Aug; 12(2):263-4. PubMed ID: 9727771
[No Abstract] [Full Text] [Related]
17. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
18. Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center.
Shirai Y; Yasuoka H; Takeuchi T; Satoh T; Kuwana M
Mod Rheumatol; 2013 Nov; 23(6):1211-20. PubMed ID: 23359006
[TBL] [Abstract][Full Text] [Related]
19. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension.
Plotkin JS; Kuo PC; Rubin LJ; Gaine S; Howell CD; Laurin J; Njoku MJ; Lim JW; Johnson LB
Transplantation; 1998 Feb; 65(4):457-9. PubMed ID: 9500616
[TBL] [Abstract][Full Text] [Related]
20. Withdrawal of epoprostenol therapy in a patient with pulmonary hypertension associated with Sjögren's syndrome.
Fujita T; Tanabe N; Kasahara Y; Sugiura T; Sakao S; Tatsumi K
Intern Med; 2014; 53(19):2237-40. PubMed ID: 25274237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
